IGF2BP2 and hepatocellular carcinoma: To further clarify whether IGF2BP2 is involved in regulating the progression of HBV‐HCC, we used a pCS‐HBV1.3 plasmid‐transfected HepG2 model to evaluate the effect of IGF2BP2 on the biological behavior of HBV‐HCC.